Ariad Pharmaceuticals

An FDA Advisory Panel Doubleheader
Motley Fool
Tue, 03/20/12 - 10:07 am
FDA
advisory panels
Votrient
soft tissue sarcomas
GSK
Merck
ridaforolimus
Ariad Pharmaceuticals
A Review Of My Last 3 Small Cap Bio-Pharma Picks
Seeking Alpha
Mon, 03/19/12 - 10:22 am
Ariad Pharmaceuticals
Acadia
Antares
BioSante
NuPathe
Dendreon
FDA Staff Questions Benefits of Glaxo, Merck Cancer Drugs
Bloomberg
Fri, 03/16/12 - 11:22 am
GSK
Merck
FDA
Ariad Pharmaceuticals
ridaforolimus
Votrient
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Seattle Genetics
Celldex
Arqule
Daiichi Sankyo
JNJ
Medivation
Dendreon
Aveo Pharmaceutical
Ariad Pharmaceuticals
AstraZeneca
Array Biopharma
Oncothyreon
Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Minyanville
Wed, 02/29/12 - 04:52 pm
Merck
Pfizer
Bristol-Myers Squibb
Chelsea Therapeutics
Affymax
Astex
JNJ
Discovery Labs
Ariad Pharmaceuticals
NeurogesX
Amgen
Ariad shares fall after posting wider 4th-qtr loss
Yahoo/AP
Wed, 02/29/12 - 10:07 am
earnings
Ariad Pharmaceuticals
What's Going on With These Biotech Stocks?
Motley Fool
Sat, 02/4/12 - 03:26 pm
Cell Therapeutics
BioSante
Teva Pharmaceuticals
Aduro BioTech
Ariad Pharmaceuticals
Merck
Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause
Seeking Alpha
Wed, 02/1/12 - 12:19 pm
Bristol-Myers Squibb
Ariad Pharmaceuticals
Inhibitex
Vertex Pharmaceuticals
Spectrum Pharmaceuticals
MannKind
6 Biotech Plays With High Risk/Reward Potential
Seeking Alpha
Sun, 01/22/12 - 12:20 pm
Vertex Pharmaceuticals
Chelsea Therapeutics
ONYX Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Cell Therapeutics
7 Large-Cap Biotech Equities With Strong Momentum Right Now
Seeking Alpha
Sat, 01/14/12 - 11:32 am
Amgen
Ariad Pharmaceuticals
Biogen
Celgene
Gilead Sciences
Vertex Pharmaceuticals
2 Positive Signs for Ariad Pharmaceuticals
Motley Fool
Wed, 12/28/11 - 10:51 am
Ariad Pharmaceuticals
ARIAD's Prolific 2011
Motley Fool
Mon, 12/19/11 - 04:02 pm
Ariad Pharmaceuticals
Ariad leukemia drug helps 47 pct of patients -study
Reuters
Mon, 12/12/11 - 10:46 am
Ariad Pharmaceuticals
Ponatinib
chronic myeloid leukemia
Five Biotech Stocks to Watch Going into Big Doctors' Meeting
Minyanville
Fri, 12/9/11 - 11:13 am
Seattle Genetics
ONYX Pharmaceuticals
Incyte
Celgene
Ariad Pharmaceuticals
Ariad Pharma: Early Efficacy, Safety of Leukemia Drug 'Striking'
TheStreet.com
Mon, 11/7/11 - 11:00 am
leukemia
Ariad Pharmaceuticals
Ponatinib
9 Biotech Stocks Trading At Steepest Discount To Target Price
Seeking Alpha
Sun, 10/30/11 - 12:40 pm
Inhibitex
Affymax
Alnylam
Incyte
Ziopharm
Array Biopharma
Ariad Pharmaceuticals
Xoma
Complete Genomics
Mid-size biotechs making their way
Boston Globe, MA
Sun, 10/23/11 - 11:56 am
Vertex Pharmaceuticals
Ariad Pharmaceuticals
Ironwood
Curis
Merck and Ariad say FDA will review application for their sarcoma pill ridaforolimus
Yahoo/AP
Wed, 10/5/11 - 10:52 am
FDA
sarcoma
ridaforolimus
Merck
Ariad Pharmaceuticals
2 Positive Signs for Ariad Pharmaceuticals
Motley Fool
Mon, 09/26/11 - 12:21 pm
Ariad Pharmaceuticals
Merck-Ariad Drug Under EU Review
Yahoo/Zacks
Sat, 08/20/11 - 10:00 pm
Merck
Ariad Pharmaceuticals
ridaforolimus
sarcoma

Pages